PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $45,000 | -31.8% | 18,913 | -18.8% | 0.00% | – |
| Q2 2022 | $66,000 | -7.0% | 23,284 | 0.0% | 0.00% | – |
| Q1 2022 | $71,000 | 0.0% | 23,284 | 0.0% | 0.00% | – |
| Q4 2021 | $71,000 | -56.4% | 23,284 | 0.0% | 0.00% | – |
| Q3 2021 | $163,000 | -23.5% | 23,284 | +17.8% | 0.00% | – |
| Q3 2019 | $213,000 | -90.5% | 19,774 | -48.0% | 0.00% | -100.0% |
| Q2 2018 | $2,249,000 | +837.1% | 38,018 | +1464.5% | 0.00% | – |
| Q4 2017 | $240,000 | +0.8% | 2,430 | +22.4% | 0.00% | – |
| Q3 2017 | $238,000 | -85.8% | 1,985 | -89.6% | 0.00% | -100.0% |
| Q2 2017 | $1,676,000 | +270.8% | 19,163 | +219.5% | 0.00% | +200.0% |
| Q3 2015 | $452,000 | -47.7% | 5,997 | -19.0% | 0.00% | -50.0% |
| Q2 2015 | $865,000 | – | 7,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |